PDAC: Explorers heading to Canada
The annual resources calendar turns to Canada this weekend for one of the world’s biggest and most influential mining conferences.
Stockhead
ASL acquiring lithium project in Quebec
American Salars Lithium is acquiring the Leduc East project in Quebec that has 35 known pegmatites and historical feldspar and mica production.
American Salars Lithium picks up promising Brazilian project
CSE-listed battery metals explorer American Salars Lithium has spread its wings with the acquisition of the LCT pegmatite rich Jaguaribe project in northern Brazil.
Aroa’s products hit medical use milestone
Aroa has achieved a key milestone with seven million of its soft tissue regeneration products used in medical procedures
More Stories
ASX rises on oil, tech hit by WiseTech sell-off
The ASX has risen on Friday on energy gains, while tech stocks have dropped on the back of WiseTech, Megaport sell-offs.
Cannindah looks to fill gap in Qld copper sector
Cannindah Resources could be on the tail of a resource extension at Queensland copper play as major copper producer Codelco takes note.
Break it Down: 5E Advanced Materials
In this episode, host Fraser Palamara delves into 5E Advanced Materials’ (ASX:5EA) achieving its first full truckload shipment of boric acid super sacks to a US customer.
Break it Down: AML3D
In this episode, host Fraser Palamara tells all on AML3D (ASX:AL3) more than doubling its US manufacturing capacity on the back of a successful $30 million capital raise.
MinRes strike, BHP details copper plans
In this week’s big cap miner news, MinRes holds a frosty AGM and BHP pulls back the curtain on copper spend.
Hillgrove building for copper bull run
Hillgrove Resources is aiming to become the next ASX copper success story, as it explores and grows its reborn Kanmantoo mine.
FBM stashes cash for its WA lithium projects
Future Battery Minerals has completed the sale of its 80% stake in the Nevada lithium project for $4m cash.
Long Shortz: Impact Minerals on Lake Hope
Host Fraser Palamara sits down with Impact Minerals managing director Dr Mike Jones to discuss the maiden resource at Lake Hope.
Tryptamine’s IV psilocin drug clears phase 1b study
Tryptamine Therapeutics has reached a milestone in development of its novel IV-infused psilocin formulation TRP-8803, with the drug meeting all phase 1b study objectives.
Rhythm raises $3.5m, eyes 2025 test launch
Rhythm Biosciences has raised $3.5m and plans to commercialise the second generation of its bowel cancer blood test Colostat in 2025.
Original URL: https://www.dailytelegraph.com.au/business/stockhead/page/200